Ipsen : 2023 CSM - Formalities for making available preparatory documents to the Meeting
10 Mai 2023 - 2:00PM
Ipsen : 2023 CSM - Formalities for making available preparatory
documents to the Meeting
INFORMATION RELATING TO
THE HOLDING OF THE COMBINED SHAREHOLDERS’
MEETING OF 31 MAY 2023
FORMALITIES FOR
MAKING AVAILABLE AND
CONSULTINGPREPARATORY DOCUMENTS
TO THE MEETING
Boulogne-Billancourt
(France), 10
May 2023 – The Shareholders of the Company are
invited to participate in the Combined Shareholders’ Meeting of
Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Wednesday
31 May 2023 at 3:00 p.m. (Paris time) at the Salons de l'Hôtel
des Arts et Métiers, 9 bis avenue d'Iéna, 75116 Paris.
The preliminary notice of the Meeting (“avis de
réunion”) was published in the Bulletin des Annonces Légales
Obligatoires (BALO) of 21 April 2023 and the notice of Meeting
(“avis de convocation”) will be published in the BALO on 12 May
2023. These documents, as well as the Convening notice (including
the agenda, the draft resolutions and the conditions regarding
attendance and vote), are also available on Ipsen’s website at the
following address: www.ipsen.com, under the
Investors / Shareholders’ Meetings section. Documents and
information relating to this Meeting are made available to
shareholders under the legal and regulatory conditions in
force.
The Shareholders will be asked to approve in
particular the following resolutions:
- The payment of a dividend of €1.20
per share for the financial year 2022, the ex-date being set on
2 June 2023 and the dividend payment on 6 June 2023;
- The renewal of the terms of office
of Mr. Marc de GARIDEL, Mr. Henri BEAUFOUR and Mrs. Michèle OLLIER
as Directors for a term of 4 years, maintaining the independence
Directors’ rate within the Board of Directors at a third in
accordance with the Afep-Medef Code and each gender’s proportion at
more than 40% in accordance with the law (Directors representing
the employees being not taken into account in these rates).
In accordance with applicable regulatory provisions:
- Registered shareholders may, up to
the fifth day (inclusive) before the Meeting, request from the
Company to send these documents, where appropriate at his/her
express request by electronic means. For holders of bearer shares,
the exercise of this right is subject to the presentation of a
shareholding certificate (attestation de participation) in the
bearer securities accounts managed by the authorized
intermediary.
- Any shareholder may consult these
documents at the Company’s headquarters.
Ipsen
Ipsen is a global, mid-sized biopharmaceutical
company focused on transformative medicines in Oncology, Rare
Disease and Neuroscience. With total sales of €3.0bn in FY 2022,
Ipsen sells medicines in over 100 countries. Alongside its
external-innovation strategy, the Company’s research and
development efforts are focused on its innovative and
differentiated technological platforms located in the heart of
leading biotechnological and life-science hubs: Paris-Saclay,
France; Oxford, U.K.; Cambridge, U.S.; Shanghai, China. Ipsen has
around 5,000 colleagues worldwide and is listed in Paris (Euronext:
IPN) and in the U.S. through a Sponsored Level I American
Depositary Receipt program (ADR: IPSEY). For more information,
visit ipsen.com.
- Documents availability - 2023 Ipsen Combined Shareholder's
Meeting
Ipsen (EU:IPN)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Ipsen (EU:IPN)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024